NasdaqGM - Delayed Quote USD

Larimar Therapeutics, Inc. (LRMR)

6.44 +0.11 (+1.74%)
At close: April 26 at 4:00 PM EDT
6.57 +0.13 (+2.02%)
After hours: April 26 at 4:59 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
41,758.00
41,758.00
36,526.00
50,465.00
42,804.00
Operating Income
-41,758.00
-41,758.00
-36,526.00
-50,465.00
-42,804.00
Other Income Expense
4,809.00
4,809.00
1,171.00
-171.00
322.00
Pretax Income
-36,949.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
Net Income Common Stockholders
-36,949.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
Diluted NI Available to Com Stockholders
-36,949.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
Basic EPS
-0.84
-0.84
-1.37
-2.95
-3.57
Diluted EPS
-0.84
-0.84
-1.37
-2.95
-3.57
Basic Average Shares
43,901.24
43,901.24
25,761.39
17,164.28
11,883.16
Diluted Average Shares
43,901.24
43,901.24
25,761.39
17,164.28
11,883.16
Total Operating Income as Reported
-41,758.00
-41,758.00
-36,526.00
-50,465.00
-42,804.00
Total Expenses
41,758.00
41,758.00
36,526.00
50,465.00
42,804.00
Net Income from Continuing & Discontinued Operation
-36,949.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
Normalized Income
-36,949.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
EBIT
-41,758.00
-41,758.00
-36,526.00
-50,465.00
-42,804.00
EBITDA
-41,447.00
-41,447.00
-36,208.00
-50,139.00
-42,649.00
Reconciled Depreciation
311.00
311.00
318.00
326.00
155.00
Net Income from Continuing Operation Net Minority Interest
-36,949.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
Normalized EBITDA
-41,447.00
-41,447.00
-36,208.00
-50,139.00
-42,649.00
12/31/2020 - 6/19/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AKRO Akero Therapeutics, Inc.
19.74
+4.28%
 
AVTE Aerovate Therapeutics, Inc.
21.75
+0.83%
 
MORF Morphic Holding, Inc.
28.07
+0.32%
 
LXEO Lexeo Therapeutics, Inc.
12.50
+2.80%
 
MDNAF Medicenna Therapeutics Corp.
1.8200
+30.00%
 
TYRA Tyra Biosciences, Inc.
15.67
+3.71%
 
EWTX Edgewise Therapeutics, Inc.
16.17
+1.44%
 
ENGN enGene Holdings Inc.
15.50
+5.30%
 
MLYS Mineralys Therapeutics, Inc.
11.87
+7.52%
 
ETNB 89bio, Inc.
8.26
+0.12%